-
1
-
-
84922439746
-
Pharmacokinetics of darunavir once or twice daily during and after pregnancy
-
3rd International Workshop on HIV Pediatrics. Rome, Italy, July 15-16, 2011. Poster
-
Capparelli EV, Best BM, Stek A etal. Pharmacokinetics of darunavir once or twice daily during and after pregnancy. 3rd International Workshop on HIV Pediatrics. Rome, Italy, July 15-16, 2011. Poster P72.
-
-
-
Capparelli, E.V.1
Best, B.M.2
Stek, A.3
-
2
-
-
59849126824
-
Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance
-
Furco A, Gosrani B, Nicholas S etal. Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance. AIDS 2009; 23: 434-435.
-
(2009)
AIDS
, vol.23
, pp. 434-435
-
-
Furco, A.1
Gosrani, B.2
Nicholas, S.3
-
3
-
-
77950959953
-
Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety
-
Ivanovic J, Bellagamba R, Nicastri E etal. Use of darunavir/ritonavir once daily in treatment-naive pregnant woman: pharmacokinetics, compartmental exposure, efficacy and safety. AIDS 2010; 24: 1083-1084.
-
(2010)
AIDS
, vol.24
, pp. 1083-1084
-
-
Ivanovic, J.1
Bellagamba, R.2
Nicastri, E.3
-
4
-
-
77956791964
-
Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases
-
Jaworsky D, Thompson C, Yudin MH etal. Use of newer antiretroviral agents, darunavir and etravirine with or without raltegravir, in pregnancy: a report of two cases. Antivir Ther 2010; 15: 677-680.
-
(2010)
Antivir Ther
, vol.15
, pp. 677-680
-
-
Jaworsky, D.1
Thompson, C.2
Yudin, M.H.3
-
5
-
-
70249088746
-
Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient
-
Pacanowski J, Bollens D, Poirier JM etal. Efficacy of darunavir despite low plasma trough levels during late pregnancy in an HIV-hepatitis C virus-infected patient. AIDS 2009; 23: 1923-1924.
-
(2009)
AIDS
, vol.23
, pp. 1923-1924
-
-
Pacanowski, J.1
Bollens, D.2
Poirier, J.M.3
-
6
-
-
77949384065
-
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1
-
Pinnetti C, Tamburrini E, Ragazzoni E, De Luca A, Navarra P. Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1. Antivir Ther 2010; 15: 127-129.
-
(2010)
Antivir Ther
, vol.15
, pp. 127-129
-
-
Pinnetti, C.1
Tamburrini, E.2
Ragazzoni, E.3
De Luca, A.4
Navarra, P.5
-
7
-
-
62249218967
-
Transplacental passage of ritonavir-boosted darunavir in two pregnant women
-
Ripamonti D, Cattaneo D, Cortinovis M, Maggiolo F, Suter F. Transplacental passage of ritonavir-boosted darunavir in two pregnant women. Int J STD AIDS 2009; 20: 215-216.
-
(2009)
Int J STD AIDS
, vol.20
, pp. 215-216
-
-
Ripamonti, D.1
Cattaneo, D.2
Cortinovis, M.3
Maggiolo, F.4
Suter, F.5
-
8
-
-
57349083100
-
Use of darunavir and enfuvirtide in a pregnant woman
-
Sued O, Lattner J, Gun A etal. Use of darunavir and enfuvirtide in a pregnant woman. Int J STD AIDS 2008; 19: 866-867.
-
(2008)
Int J STD AIDS
, vol.19
, pp. 866-867
-
-
Sued, O.1
Lattner, J.2
Gun, A.3
-
9
-
-
84888876556
-
A comparison of the pharmacokinetics of darunavir, atazanavir and ritonavir during pregnancy and post-partum
-
19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, USA, March, 2012 [Poster 1013].
-
Colbers A, Moltó J, Ivanovic J etal. A comparison of the pharmacokinetics of darunavir, atazanavir and ritonavir during pregnancy and post-partum. 19th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, USA, March, 2012 [Poster 1013].
-
-
-
Colbers, A.1
Moltó, J.2
Ivanovic, J.3
-
10
-
-
25144516296
-
Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach
-
Anderson GD. Pregnancy-induced changes in pharmacokinetics: a mechanistic-based approach. Clin Pharmacokinet 2005; 44: 989-1008.
-
(2005)
Clin Pharmacokinet
, vol.44
, pp. 989-1008
-
-
Anderson, G.D.1
-
11
-
-
9144268274
-
Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women
-
Acosta EP, Bardeguez A, Zorrilla CD etal. Pharmacokinetics of saquinavir plus low-dose ritonavir in human immunodeficiency virus-infected pregnant women. Antimicrob Agents Chemother 2004; 48: 430-436.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 430-436
-
-
Acosta, E.P.1
Bardeguez, A.2
Zorrilla, C.D.3
-
12
-
-
33748911183
-
Reduced lopinavir exposure during pregnancy
-
Stek AM, Mirochnick M, Capparelli E etal. Reduced lopinavir exposure during pregnancy. AIDS 2006; 20: 1931-1939.
-
(2006)
AIDS
, vol.20
, pp. 1931-1939
-
-
Stek, A.M.1
Mirochnick, M.2
Capparelli, E.3
-
13
-
-
34547780413
-
Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers
-
Scholler-Gyure M, Kakuda TN, Sekar V etal. Pharmacokinetics of darunavir/ritonavir and TMC125 alone and coadministered in HIV-negative volunteers. Antivir Ther 2007; 12: 789-796.
-
(2007)
Antivir Ther
, vol.12
, pp. 789-796
-
-
Scholler-Gyure, M.1
Kakuda, T.N.2
Sekar, V.3
-
14
-
-
0025139714
-
Plasma protein binding of drugs in pregnancy and in neonates
-
Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990; 18: 20-36.
-
(1990)
Clin Pharmacokinet
, vol.18
, pp. 20-36
-
-
Notarianni, L.J.1
-
15
-
-
77956565656
-
Longitudinal study of CD4+ cell counts in HIV-negative pregnant patients
-
Towers CV, Rumney PJ, Ghamsary MG. Longitudinal study of CD4+ cell counts in HIV-negative pregnant patients. J Matern Fetal Neonatal Med 2010; 23: 1091-1096.
-
(2010)
J Matern Fetal Neonatal Med
, vol.23
, pp. 1091-1096
-
-
Towers, C.V.1
Rumney, P.J.2
Ghamsary, M.G.3
-
16
-
-
84876412798
-
Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy
-
doi:10.1097/QAI.0b013e318285 [Epub ahead of print].
-
Cespedes MS, Castor D, Ford SL etal. Steady-state pharmacokinetics, cord blood concentrations, and safety of ritonavir-boosted fosamprenavir in pregnancy. J Acquir Immune Defic Syndr 2013; doi:10.1097/QAI.0b013e318285 [Epub ahead of print].
-
(2013)
J Acquir Immune Defic Syndr
-
-
Cespedes, M.S.1
Castor, D.2
Ford, S.L.3
-
17
-
-
80053383846
-
Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women
-
Conradie F, Zorrilla C, Josipovic D etal. Safety and exposure of once-daily ritonavir-boosted atazanavir in HIV-infected pregnant women. HIV Med 2011; 12: 570-579.
-
(2011)
HIV Med
, vol.12
, pp. 570-579
-
-
Conradie, F.1
Zorrilla, C.2
Josipovic, D.3
-
18
-
-
79953052608
-
Atazanavir pharmacokinetics with and without tenofovir during pregnancy
-
Mirochnick M, Best BM, Stek AM etal. Atazanavir pharmacokinetics with and without tenofovir during pregnancy. J Acquir Immune Defic Syndr 2011; 56: 412-419.
-
(2011)
J Acquir Immune Defic Syndr
, vol.56
, pp. 412-419
-
-
Mirochnick, M.1
Best, B.M.2
Stek, A.M.3
-
19
-
-
84876296360
-
Protein binding of lopinavir and ritonavir during four phases of pregnancy: implications for treatment guidelines
-
Patterson KB, Dumond JB, Prince HA etal. Protein binding of lopinavir and ritonavir during four phases of pregnancy: implications for treatment guidelines. J Acquir Immune Defic Syndr 2013; 63: 51-58.
-
(2013)
J Acquir Immune Defic Syndr
, vol.63
, pp. 51-58
-
-
Patterson, K.B.1
Dumond, J.B.2
Prince, H.A.3
-
20
-
-
34347329093
-
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial
-
Madruga JV, Berger D, McMurchie M etal. Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial. Lancet 2007; 370: 49-58.
-
(2007)
Lancet
, vol.370
, pp. 49-58
-
-
Madruga, J.V.1
Berger, D.2
McMurchie, M.3
|